Vol.22 No.6

Letter

Additional use of tacrolimus after switching to tocilizumab therapy in patients with primary lack of efficacy of infliximab therapy for rheumatoid arthritis

Authors

Shunsuke Mori1

  • Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto, 861-1196, Japan
Received:

31 October 2011

Accepted:

5 January 2012

Published online:

16 February 2012

Full Text

PDF (member's only)

Abstract

Without Abstract

Key words

Infliximab - Rheumatoid arthritis - Switching - Tacrolimus - Tocilizumab